Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF, and combined VEGF plus BMP-6 in vitro

References

• Boden SD, Liu Y, Hair GA, Helms JA, Hu D, Racine M, Nanes MS, Titus L. 1998. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology. 139 12: 5125–5134.
   Google Scholar
• Chen SJ, Artlett CM, Jimenez SA, Varga J. 1998. Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene. 215:101–110.
   PubMedGoogle Scholar
• Chen HT, Lee MJ, Chen CH, Chuang SC, Chang LF, Ho ML, Hung SH, Fu YC, Wang YH, Wang HI, Wang GJ, Kang L, Chang JK. 2011. Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med. 16 3: 582–593.
   Google Scholar
• Cui F, Wang X, Liu X, Dighe AS, Balian G, Cui Q. 2010. VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells. Growth Factors. 28 5: 306–317.
   PubMed Web of Science ®Google Scholar
• Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am. 2003a; 85:19–28.
   Google Scholar
• Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res. 2003b; 44:305–311.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8:315–317.
   PubMed Web of Science ®Google Scholar
• Estes BT, Wu AW, Guilak F. 2006. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum. 54 4: 1222–1232.
   PubMedGoogle Scholar
• Gabbay JS, Heller JB, Mitchell SA, Zuk PA, Spoon DB, Wasson KL, Jarrahy R, Benhaim P, Bradley JP. 2006. Osteogenic potentiation of human adipose-derived stem cells in a 3-dimensional matrix. Ann Plast Surg. 57 1: 89–93.
   Google Scholar
• Garcia P, Pieruschka A, Klein M, Tami A, Histing T, Holstein JH, Scheuer C, Pohlemann T, Menger MD. 2012. Temporal and spatial vascularization patterns of unions and nonunions: Role of vascular endothelial growth factor and bone morphogenetic proteins. J Bone Joint Surg Am. 94:49–58.
   Google Scholar
• Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Richter W. 2005. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res. 20 11: 2028–2035 Epub 2005 Jul 5.
   PubMed Web of Science ®Google Scholar
• Gregory CA, Gunn WG, Peister A, Prockop DJ. 2004. An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem. 329 1: 77–84.
   PubMed Web of Science ®Google Scholar
• Hanada K, Dennis JE, Caplan AI. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res. 12:1606–1614.
   PubMed Web of Science ®Google Scholar
• Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B. 2001. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem. 81 2: 284–294.
   PubMed Web of Science ®Google Scholar
• Hou H, Zhang X, Tang T, Dai K, Ge R. 2009. Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1. Biotechnol Lett. 31 8: 1183–1189 Epub 2009 Apr 24.
   Google Scholar
• Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ. 2005. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res. 20 5: 848–857 Epub 2004 Dec 20.
   PubMed Web of Science ®Google Scholar
• Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He TC. 2004. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 11:1312–1320.
   PubMed Web of Science ®Google Scholar
• Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. 2009. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 30 14: 2816–2825 Epub 2009 Feb 20.
   PubMed Web of Science ®Google Scholar
• Kern B, Shen J, Starbuck M, Karsenty G. 2001. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem. 276:7101–7107.
   PubMed Web of Science ®Google Scholar
• Krause U, Seckinger A, Gregory CA. 2011. Assays of osteogenic differentiation by cultured human mesenchymal stem cells. Methods Mol Biol. 698:215–230.
   Google Scholar
• Kubo S, Cooper GM, Matsumoto T, Phillippi JA, Corsi KA, Usas A, Li G, Fu FH, Huard J. 2009. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum. 60 1: 155–165.
   PubMed Web of Science ®Google Scholar
• Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. 2003. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun. 309:689–694.
   Google Scholar
• Li X, Cui Q, Kao C, Wang GJ, Balian G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone. 2003a; 33:652–659.
   PubMed Web of Science ®Google Scholar
• Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther. 2003b; 10:1735–1743.
   PubMed Web of Science ®Google Scholar
• Li G, Corsi-Payne K, Zheng B, Usas A, Peng H, Huard J. 2009. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A. 15 8: 2123–2133.
   Google Scholar
• Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T. 2008. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem. 283:29119–29125.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Cooper GM, Gharaibeh B, Meszaros LB, Li G, Usas A, Fu FH, Huard J. 2009. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum. 60 5: 1390–1405.
   PubMed Web of Science ®Google Scholar
• Mizuno D, Agata H, Furue H, Kimura A, Narita Y, Watanabe N, Ishii Y, Ueda M, Tojo A, Kagami H. 2010. Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum. Growth Factors. 28:34–43.
   PubMed Web of Science ®Google Scholar
• Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:17–29.
   PubMed Web of Science ®Google Scholar
• Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. 2004. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs. 176:109–119.
   PubMed Web of Science ®Google Scholar
• Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. 2008. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone. 43 5: 931–940 Epub 2008 Jul 14.
   PubMed Web of Science ®Google Scholar
• Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 110 6: 751–759.
   PubMed Web of Science ®Google Scholar
• Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J. 2005. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 20 11: 2017–2027 Epub 2005 Jul 18.
   PubMed Web of Science ®Google Scholar
• Puleo DA. 1997. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J Cell Physiol. 173:93–101.
   PubMed Web of Science ®Google Scholar
• Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 131:324–336.
   PubMed Web of Science ®Google Scholar
• Saito M, Marumo K. 2010. Collagen cross-links as a determinant of bone quality: A possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 21:195–214.
   PubMed Web of Science ®Google Scholar
• Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. 2008. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci. 108 1: 18–31 Epub 2008 Sep 6.
   Google Scholar
• Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Löwik CW, ten Dijke P. 2007. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci. 120 Pt 6: 964–972 Epub 2007 Feb 20.
   Google Scholar
• Tallone T, Realini C, Böhmler A, Kornfeld C, Vassalli G, Moccetti T, Bardelli S, Soldati G. 2011. Adult human adipose tissue contains several types of multipotent cells. J Cardiovasc Transl Res. 4:200–210.
   PubMed Web of Science ®Google Scholar
• Turner CH. 2006. Bone strength: Current concepts. Ann NY Acad Sci. 1068:429–446.
   PubMed Web of Science ®Google Scholar
• Verrecchia F, Rossert J, Mauviel A. 2001. Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: Implications for the treatment of tissue fibrosis. J Invest Dermatol. 116:755–763.
   PubMed Web of Science ®Google Scholar
• Wang X, Cui F, Madhu V, Dighe AS, Balian G, Cui Q. 2011. Combined VEGF and LMP-1 delivery enhances osteoprogenitor cell differentiation and ectopic bone formation. Growth Factors. 29 1: 36–48.
   PubMed Web of Science ®Google Scholar
• Weinand C, Nabili A, Khumar M, Dunn JR, Ramella-Roman J, Jeng JC, Jordan MH, Tabata Y. 2011. Factors of osteogenesis influencing various human stem cells on third-generation gelatin/B-tricalcium phosphate scaffold material. Rejuvenation Res. 14 2: 185–194 Epub 2011 Jan 16.
   PubMed Web of Science ®Google Scholar
• Young S, Patel ZS, Kretlow JD, Murphy MB, Mountziaris PM, Baggett LS, Ueda H, Tabata Y, Jansen JA, Wong M, Mikos AG. 2009. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A. 15 9: 2347–2362.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang M, Lin L, Chen P, Ma KT, Zhou CY, Ao YF. 2006. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif Tissue Int. 79 3: 169–178 Epub 2006 Sep 11.
   PubMed Web of Science ®Google Scholar
• Zuk P, Chou YF, Mussano F, Benhaim P, Wu BM. 2011. Adipose-derived stem cells and BMP2: Part 2.BMP2 may not influence the osteogenic fate of human adipose-derived stem cells. Connect Tissue Res. 52:119–132.
   PubMed Web of Science ®Google Scholar